triptonide has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Meng, M; Xiang, S; Zhang, B; Zhang, T; Zhao, Z; Zhou, Q | 1 |
| Chen, Y; Gao, Y; Jia, Y; Liu, X; Ma, D; Wang, C; Wang, Z; Yang, Y; Yuan, J; Zeng, F; Zhu, Z | 1 |
2 other study(ies) available for triptonide and Cancer of Stomach
| Article | Year |
|---|---|
Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Receptor, Notch1; Signal Transduction; Stomach Neoplasms; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.
Topics: Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Fibroblasts; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; MicroRNAs; Neoplasm Invasiveness; Oncogenes; Stomach; Stomach Neoplasms; Triterpenes; Up-Regulation | 2017 |